The centre in Porto, Portugal is larger than the company's previous premises, and is hoped to support its expansion plans
FairJourney Biologics, an antibody discovery and optimisation specialist, has relocated to a larger, purpose-built research centre in Porto, Portugal. The premises are hoped to support the company’s expansion and plans for further growth.
FairJourney now occupies more than 200,000 sqft, with the premises containing 140 laboratories, meeting rooms and social areas, as well as green spaces and leisure areas designed to promote employee well-being.
The facility will house more projects and industry leading equipment, enabling the company to support more clients and carry out research into antibody-based drugs.
António Parada, CEO of FairJourney Biologics commented: “Our relocation into a new research center demonstrates our trajectory toward further growth. The move is an exciting development for the Company and gives us the flexibility to support more projects and continue to expand our market-leading antibody library.”